| Schedule of derivative liabilities |
| Schedule of derivative liabilities | |
| | |
| |
| | |
June 30, 2022 | |
| The financings giving rise to derivative financial instruments | |
Indexed
Shares | | |
Fair
Values | |
| Compound embedded derivatives | |
| 19,585,533,532 | | |
| (6,911,764 | ) |
| Total | |
| 19,585,533,532 | | |
| (6,911,764 | ) |
The following tables summarize the components
of the Company’s derivative liabilities and linked common shares as of March 31, 2022:
| | |
March 31, 2022 | |
| The financings giving rise to derivative financial instruments | |
Indexed
Shares | | |
Fair
Values | |
| Compound embedded derivatives | |
| 559,931,126 | | |
$ | (3,831,191 | ) |
| Total | |
| 559,931,126 | | |
$ | (3,831,191 | ) |
The following table summarizes the effects
on the Company’s (loss) gain associated with changes in the fair values of the derivative financial instruments by type of
financing for the three months ended June 30, 2022 and 2021:
| | |
June 30, | | |
June 30, | |
| | |
2022 | | |
2021 | |
| | |
| | |
| |
| Compound embedded derivatives | |
$ | (2,809,276 | ) | |
$ | 310,871 | |
| Day one derivative loss | |
| (194,323 | ) | |
| – | |
| Total | |
$ | (3,003,599 | ) | |
$ | 310,871 | |
|
| Schedule of changes in fair value of derivatives |
| Schedule of changes in fair value of derivatives | |
| | |
| |
| | |
June 30, | | |
March 31, | |
| | |
2022 | | |
2022 | |
| | |
| | |
| |
| Beginning balance | |
$ | 3,831,191 | | |
$ | 1,137,623 | |
| Issuances: | |
| | | |
| | |
| Compound embedded derivatives | |
| 326,921 | | |
| 2,038,843 | |
| Conversions | |
| (178,146 | ) | |
| (328,638 | ) |
| Derivative extinguished / debt repaid in cash | |
| (71,801 | ) | |
| (243,300 | ) |
| Loss on changes in fair value inputs and assumptions reflected in income | |
| 2,809,276 | | |
| 1,181,178 | |
| Day one derivative expense | |
| 194,323 | | |
| 45,485 | |
| Total | |
$ | 6,911,764 | | |
$ | 3,831,191 | |
|